We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBOC:NASDAQInternational Bancshares Corporation Analysis

Data as of 2026-07-30 - not real-time

$76.63

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

International Bancshares is trading marginally above its short‑term moving average while still lagging the longer‑term averages, suggesting limited near‑term momentum. The RSI sits in the neutral zone and the MACD has turned bearish, with decreasing volume adding a cautionary tone, yet the broader trend remains bullish and market sentiment is in an extreme‑greed phase. Fundamentally, the stock appears attractively priced relative to its earnings multiple, which is comfortably below the sector average, and the discounted cash‑flow model indicates a notable upside. The dividend payout is modest and supported by strong operating margins and ample cash on hand, while leverage is low and return metrics are solid, painting a picture of a financially resilient regional bank.
Given the low beta and modest volatility, the equity offers a defensive profile within the financial services sector. However, regulatory and sector‑specific headwinds typical for regional banks temper the outlook, making the stock best suited for investors comfortable with a blend of value and growth attributes and seeking steady income.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price testing a nearby support zone
  • bearish MACD crossover
  • decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation gap versus discounted cash‑flow estimate
  • moderate upside potential
  • sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • stable earnings and strong operating margins
  • low beta indicating defensive characteristics
  • solid balance sheet with ample cash and low leverage

Key Metrics & Analysis

Financial Health

Revenue Growth5.40%
Profit Margin49.85%
P/E Ratio11.4
ROE13.51%
ROA2.52%
P/B Ratio1.4
Op. Cash Flow$471.3M
Industry P/E18.0

Technical Analysis

TrendBullish
RSI53.9
Support$74.39
Resistance$78.02
MA 20$76.10
MA 50$74.90
MA 200$70.58
MACDBearish
VolumeDecreasing
Fear & Greed Index88.82

Valuation

Fair Value$84.29
Target Price$87.00
Upside/Downside13.53%
GradeUndervalued
TypeBlend
Dividend Yield1.86%

Risk Assessment

Beta0.51
Volatility19.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.